Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interferon regulatory factor 1 (IRF-1) is a transcription factor encoded by the *IRF1* gene. It was the first member identified in the IRF family, which regulates interferon (particularly type I IFN) expression and various interferon-inducible genes[2][3]. IRF-1 activates or represses a wide range of genes by binding to interferon-stimulated response elements (ISREs) in gene promoters. It is structurally defined by a conserved N-terminal helix-turn-helix DNA-binding domain and a distinct C-terminal regulatory region[1][4]. Functionally, IRF-1 is critical in both innate and adaptive immune responses, cell cycle checkpoint control, apoptosis, DNA damage response, and tumor suppression, and its loss or altered function has been associated with increased cancer risk and altered immune regulation[5][3][2]. IRF-1 does not currently have any known direct small-molecule drug modulators, but its expression and activity may serve as a biomarker, particularly in oncology and immune modulation research[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interferon regulatory factor 1 (IRF-1).